An Adaptive, Two Part, Two Period, Single Sequence, Drug Interaction Study Between Dolutegravir 50 mg and Prednisone in Adult Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 04 Nov 2011
At a glance
- Drugs Dolutegravir; Prednisone
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 04 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 04 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Oct 2011 Actual patient number is 12 as reported by ClinicalTrials.gov.